Clinical Use of Propranolol Reduces Biomarkers of Proliferation in Gastric Cancer

Gastric cancer has one of the highest mortality rate in the world, but the treatment is still limited. Building on previous studies, mechanistic studies on propranolol in gastric cancer mice models and gastric cancer patients were performed. Propranolol inhibited the in vitro proliferation of gastri...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Hu, Qian, Liao, Ping, Li, Wei, Hu, Jiali, Chen, Cuiyu, Zhang, Yu, Wang, Yang, Chen, Ling, Song, Kun, Liu, Jie, Zhang, Wei, Li, Qing, McLeod, Howard L., He, Yijing
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108985/
https://ncbi.nlm.nih.gov/pubmed/33981600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.628613
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia